Following the 2010 adoption of the US ‘Sunshine Act’, several EU member states have recently introduced statutory obligations for life...
Cortex - Life Sciences Insights
Cell and gene therapies are emerging at full speed, showing the potential to transform the future of medicine, but traditional pricing...
Fantastic panel session at FT Global Pharmaceutical and Biotechnology on “Big data, big deal”. The questions on data are still questions,...
With trade terms still unfinalised, stockpiling of medicines and the sourcing of alternative transportation and routes has become a...
1 November 2018 marks a turning point in relation to the use of medicinal cannabis in the UK. The Misuse of Drugs (Amendments) (Cannabis...
Ordinarily only one market authorisation is granted to an applicant for a specific medicinal product, however the applicant/holder can...
The FT commented earlier today on the highly provocative report "The Biomedical Bubble" published by Nesta, the charity which, in its own...
Two weeks after a certain tech giant announced its reported $1 billion acquisition of PillPack, I consider whether this move by the...
If anyone wondered why have a two-house system of parliament, perhaps a good starting point would be to read the opinion of the Science...
Being 'sent to Coventry' is not ordinarily something one wants to hear, but at the end of April for the last few years I have made my...
Reading this article by Clive Cookson at the FT, one can't help but experience differing emotions. Initially, you feel a sense of...
Between 9 and 11 April I will be in Basilea with Johan Renes from DLA Piper Amsterdam and Paula Gonzalez from DLA Piper Madrid at the...
It is going to be interesting to watch the continued tussle between the online and community pharamacy sectors. Both offer convincing...
Very interesting article about the vision of the NHS to transform and consolidate our public healthcare system to drive further...
Join members of DLA Piper's Brexit Committee for a webinar hosted right after this weeks EU summit ends. They will cut through the noise...
A Brexit transition period to 31 December 2020 is good news for the Life Sciences industry. Brexit negotiators have now agreed Article...
